Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)

NCT00407303

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • NW Georgia Oncology Centers Marietta, Georgia, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Medical Center Buffalo, New York, United States
View Trial Details
Completed

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

NCT00006747

Conditions
Graft Versus Host Disease, Graft vs Host Disease, Hemic and Lymphatic Diseases, +9 more
Locations
  • Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
  • University of California San Diego Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
View all 48 locations
View Trial Details
Completed

Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

NCT00020943

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center Los Angeles, California, United States
View all 81 locations
View Trial Details
Completed

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00032019

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center Los Angeles, California, United States
  • Naval Medical Center - San Diego San Diego, California, United States
View all 81 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

NCT00006125

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Diego San Diego, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
View all 76 locations
View Trial Details
Completed

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

NCT00005964

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
  • University of California San Diego Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
View all 47 locations
View Trial Details
Completed

Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

NCT00003849

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
View all 21 locations
View Trial Details
Completed

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

NCT00553501

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Kaiser Permanente Medical Office -Vandever Medical Office San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Middlesex Hospital Cancer Center Middletown, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
View all 43 locations
View Trial Details

Related conditions